Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 45K
2: EX-99.1 Miscellaneous Exhibit HTML 29K
6: R1 Cover HTML 45K
9: XML IDEA XML File -- Filing Summary XML 11K
7: XML XBRL Instance -- omi-20220913_htm XML 21K
8: EXCEL IDEA Workbook of Financial Reports XLSX 8K
4: EX-101.LAB XBRL Labels -- omi-20220913_lab XML 67K
5: EX-101.PRE XBRL Presentations -- omi-20220913_pre XML 33K
3: EX-101.SCH XBRL Schema -- omi-20220913 XSD 10K
10: JSON XBRL Instance as JSON Data -- MetaLinks 11± 16K
11: ZIP XBRL Zipped Folder -- 0000075252-22-000052-xbrl Zip 27K
Registrant’s telephone number, including area code i(804)i723-7000
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon Stock, $2 par value per share
iOMI
iNew
York Stock Exchange
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):
io
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
io
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
io
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
io
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth companyioIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 7.01
Regulation FD Disclosure.
Owens & Minor, Inc. (the “Company”) will participate in the 2022 Baird Global Healthcare Conference on Tuesday, September
13, 2022. The Company’s executive leadership team will present at 12:15 p.m. E.T. on Tuesday, September 13, 2022 using the slides attached hereto as Exhibit 99.1 and incorporated by this reference. The presentation will be webcasted live and may be accessed at www.owens-minor.com under the investor relations section at investors.owens-minor.com/events-presentations/. The webcast will be archived and available for replay on the website.
The information
in Exhibit 99.1 is being furnished pursuant to Item 7.01 of Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document)
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.